Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rituximab and DepoCyte in PCL and DLBCL with CNS Involvement
NCT00553943Phase 2Completed
- Sponsor
- Lymphoma Study Association
- Start
- Jul 2007
- Primary completion
- Jun 2012
- Modality
- Small Molecules, Monoclonal Antibodies
- Countries
- 2
01
Overview
A Phase 2 trial of rituximab, cytarabine in primary central nervous system lymphoma (PCNSL), diffuse large B-cell lymphoma (DLBCL), sponsored by Lymphoma Study Association. Started Jul 2007; status: completed.
02
Drugs
rituximabcytarabine
03
Conditions
primary central nervous system lymphoma (PCNSL)diffuse large B-cell lymphoma (DLBCL)
Beyond the preview
Go deeper on NCT00553943.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00553943.